Experimental transfusion-induced Babesia microti infection: Dynamics of parasitemia and immune responses in a rhesus macaque model

Transfusion

Volumn 56, Issue 6, 2016, Pages 1508-1519

  Gumber, Sanjeev ^a,b   Nascimento, Fernanda S ^c   Rogers, Kenneth A ^c   Bishop, Henry S ^c   Rivera, Hilda N ^c   Xayavong, Maniphet V ^c   Devare, Sushil G ^d   Schochetman, Gerald ^d   Amancha, Praveen K ^a   Qvarnstrom, Yvonne ^c   Wilkins, Patricia P ^c   Villinger, François ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d ABBOTT DIAGNOSTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CD14 ANTIGEN; CD16 ANTIGEN; GLYCOPROTEIN P 15095; PROTOZOON ANTIBODY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; BABESIA MICROTI; BLOOD SMEAR; CONTROLLED STUDY; CORRELATIONAL STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HAMSTER; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; MONOCYTE; MYELOID DENDRITIC CELL; NONHUMAN; PARASITEMIA; PIROPLASMOSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE STUDY; RHESUS MONKEY; TRANSFUSION ASSOCIATED BABESIOSIS; ANIMAL; BLOOD; BLOOD TRANSFUSION REACTION; DISEASE MODEL; HAPLORHINI; IMMUNOLOGY; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; KINETICS; PARASITOLOGY; TRANSMISSION;

ANIMALS; ANTIBODIES, PROTOZOAN; BABESIOSIS; CRICETINAE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HAPLORHINI; KINETICS; MACACA MULATTA; PARASITEMIA; POLYMERASE CHAIN REACTION; TRANSFUSION REACTION;

EID: 84975770097     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13521     Document Type: Article

References (47)

1. Vannier E, Krause PJ., Human babesiosis. N Engl J Med 2012; 366: 2397-407.
2. Krause PJ., Babesiosis. Med Clin North Am 2002; 86: 361-73.
3. Rowin KS, Tanowitz HB, Rubinstein A, et al., Babesiosis in asplenic hosts. Trans R Soc Trop Med Hyg 1984; 78: 442-4.
4. Rosner F, Zarrabi MH, Benach JL, et al., Babesiosis in splenectomized adults. Review of 22 reported cases. Am J Med 1984; 76: 696-701.
5. Wittner M, Rowin KS, Tanowitz HB, et al., Successful chemotherapy of transfusion babesiosis. Ann Intern Med 1982; 96: 601-4.
6. Krause PJ, Lepore T, Sikand VK, et al., Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 2000; 343: 1454-8.
7. Krause PJ, McKay K, Gadbaw J, et al., Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 2003; 68: 431-6.
8. Leiby DA., Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev 2011; 24: 14-28.
9. Vannier E, Gewurz BE, Krause PJ., Human babesiosis. Infect Dis Clin North Am 2008; 22: 469-88, viii-ix.
10. White DJ, Talarico J, Chang HG, et al., Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998; 158: 2149-54.
11. Hatcher JC, Greenberg PD, Antique J, et al., Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001; 32: 1117-25.
12. Vannier EG, Diuk-Wasser MA, Ben Mamoun C, et al., Babesiosis. Infect Dis Clin North Am 2015; 29: 357-70.
13. Herwaldt BL, Linden JV, Bosserman E, et al., Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155: 509-19.
14. Gray J, Zintl A, Hildebrandt A, et al., Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity. Ticks Tick Borne Dis 2010; 1: 3-10.
15. Krause PJ, Telford S III, Spielman A, et al., Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia. J Clin Microbiol 1996; 34: 2791-4.
16. Krause PJ, Telford SR 3rd, Ryan R, et al., Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis 1994; 169: 923-6.
17. Moritz ED, Winton CS, Johnson ST, et al., Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States. Transfusion 2014; 54: 2226-36.
18. Bloch EM, Lee TH, Krause PJ, et al., Development of a real-time polymerase chain reaction assay for sensitive detection and quantitation of Babesia microti infection. Transfusion 2013; 53: 2299-306.
19. Teal AE, Habura A, Ennis J, et al., A new real-time PCR assay for improved detection of the parasite Babesia microti. J Clin Microbiol 2012; 50: 903-8.
20. Levin AE, Williamson PC, Erwin JL, et al., Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion 2014; 54: 2237-44.
21. Blood Products Advisory Committee Meeting. Strategies for implementation of antibody and nucleic acid-based testing for Babesia microti in blood donors [Internet]. U.S. Food and Drug Administration: Silver Spring (MD); 2015 [cited 2015 July 2]. Available from: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/ucm441228.htm.
22. Stewart CB, Disotell TR., Primate evolution-in and out of Africa. Curr Biol 1998; 8: R582-8.
23. Ruebush TK 2nd, Collins WE, Healy GR, et al., Experimental Babesia microti infections in non-splenectomized Macaca mulatta. J Parasitol 1979; 65: 144-6.
24. Ruebush TK 2nd, Collins WE, Warren M., Experimental Babesia microti infections in Macaca mulatta: recurrent parasitemia before and after splenectomy. Am J Trop Med Hyg 1981; 30: 304-7.
25. Ruebush TK 2nd, Piesman J, Collins WE, et al., Tick transmission of Babesia microti to rhesus monkeys (Macaca mulatta). Am J Trop Med Hyg 1981; 30: 555-9.
26. Jeong YI, Hong SH, Cho SH, et al., Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection. PLoS One 2012; 7: e46553.
27. Li Y, Terkawi MA, Nishikawa Y, et al., Macrophages are critical for cross-protective immunity conferred by Babesia microti against Babesia rodhaini infection in mice. Infect Immun 2012; 80: 311-20.
28. Ameri M., Laboratory diagnosis of malaria in nonhuman primates. Vet Clin Pathol 2010; 39: 5-19.
29. Persing DH, Mathiesen D, Marshall WF, et al., Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992; 30: 2097-103.
30. Hojgaard A, Lukacik G, Piesman J., Detection of Borrelia burgdorferi, Anaplasma phagocytophilum and Babesia microti, with two different multiplex PCR assays. Ticks Tick Borne Dis 2014; 5: 349-51.
31. Chisholm ES, Sulzer AJ, Ruebush TK 2nd,. Indirect immunofluorescence test for human Babesia microti infection: antigenic specificity. Am J Trop Med Hyg 1986; 35: 921-5.
32. Whitaker BI, Hinkins S., The 2011 national blood collection and utilization survey report [Internet]. Rockville (MD): U.S. Department of Health and Human Services; 2011 [cited 2015 Aug 3]. Available from: http://www.hhs.gov/ash/bloodsafety/2011-nbcus.pdf.
33. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2012 [Internet]. Silver Spring (MD): FDA/CBER Office of Communication, Outreach, and Development; 2012 [cited 2015 May 12]. Available from: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm.
34. Stramer SL., Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser 2014; 9: 30-6.
35. Wozniak EJ, Lowenstine LJ, Hemmer R, et al., Comparative pathogenesis of human WA1 and Babesia microti isolates in a Syrian hamster model. Lab Anim Sci 1996; 46: 507-15.
36. Weiss LM, Wittner M, Wasserman S, et al., Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J Infect Dis 1993; 168: 1289-92.
37. Matsubara J, Koura M, Kamiyama T., Infection of immunodeficient mice with a mouse-adapted substrain of the gray strain of Babesia microti. J Parasitol 1993; 79: 783-6.
38. Leiby DA, Johnson ST, Won KY, et al., A longitudinal study of Babesia microti infection in seropositive blood donors. Transfusion 2014; 54: 2217-25.
39. Krause PJ, Spielman A, Telford SR 3rd, et al., Persistent parasitemia after acute babesiosis. N Engl J Med 1998; 339: 160-5.
40. Tsai IJ, Zarowiecki M, Holroyd N, et al., The genomes of four tapeworm species reveal adaptations to parasitism. Nature 2013; 496: 57-63.
41. Gubernot DM, Nakhasi HL, Mied PA, et al., Transfusion-transmitted babesiosis in the United States: summary of a workshop. Transfusion 2009; 49: 2759-71.
42. Tonnetti L, Eder AF, Dy B, et al., Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009; 49: 2557-63.
43. Homer MJ, Bruinsma ES, Lodes MJ, et al., A polymorphic multigene family encoding an immunodominant protein from Babesia microti. J Clin Microbiol 2000; 38: 362-8.
44. Jackson AP, Otto TD, Darby A, et al., The evolutionary dynamics of variant antigen genes in Babesia reveal a history of genomic innovation underlying host-parasite interaction. Nucleic Acids Res 2014; 42: 7113-31.
45. Wei Q, Tsuji M, Zamoto A, et al., Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic. J Clin Microbiol 2001; 39: 2178-83.
46. van Duivenvoorde LM, Voorberg-van der Wel A, van der Werff NM, et al., Suppression of Plasmodium cynomolgi in rhesus macaques by coinfection with Babesia microti. Infect Immun 2010; 78: 1032-9.
47. Terkawi MA, Cao S, Herbas MS, et al., Macrophages are the determinant of resistance to and outcome of nonlethal Babesia microti infection in mice. Infect Immun 2015; 83: 8-16.